Advertisement
BEBE vs XXI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEBE is a Hold and XXI is a Hold.
BEBE's RSI Oscillator recovers from oversold territory
The RSI Indicator for BEBE moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 18 of the 28 cases the stock moved higher. This puts the odds of a move higher at 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 27 of 60 cases where BEBE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 45%.
The Aroon Indicator entered an Uptrend today. In 49 of 100 cases where BEBE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BEBE as a result. In 58 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for BEBE turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 31 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
BEBE broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 7 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. BEBE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.372) is normal, around the industry mean (-543.087). P/E Ratio (503.500) is within average values for comparable stocks, (118.532). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (15.932). BEBE's Dividend Yield (0.794) is considerably higher than the industry average of (0.020). BEBE's P/S Ratio (0.000) is very low in comparison to the industry average of (3.158).
XXI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 16, 2026
XXI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 10 of 12 cases where XXI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 12 of 20 cases where XXI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
Following a +6.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where XXI advanced for three days, in 56 of 85 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XXI as a result. In 16 of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for XXI turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 21 similar instances when the indicator turned negative. In 14 of the 21 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
XXI moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for XXI crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 40%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for XXI entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.872) is normal, around the industry mean (1.158). P/E Ratio (0.000) is within average values for comparable stocks, (8.484). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.327). Dividend Yield (0.000) settles around the average of (4.151) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (27.566).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. XXI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
BEBE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 7 | |
SMR RATING 1..100 | 90 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 44 | |
SEASONALITY SCORE 1..100 | 70 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BEBE | XXI | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 64% | N/A |
| Stochastic ODDS (%) | 3 days ago 45% | 3 days ago 60% |
| Momentum ODDS (%) | 3 days ago 70% | 4 days ago 53% |
| MACD ODDS (%) | 3 days ago 77% | 4 days ago 67% |
| TrendWeek ODDS (%) | 3 days ago 48% | 3 days ago 59% |
| TrendMonth ODDS (%) | 3 days ago 39% | 3 days ago 83% |
| Advances ODDS (%) | N/A | 5 days ago 66% |
| Declines ODDS (%) | N/A | 7 days ago 85% |
| BollingerBands ODDS (%) | 3 days ago 59% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 49% | 3 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BEBE’s FA Score shows that 1 FA rating(s) are green while XXI’s FA Score has 1 green FA rating(s).
- BEBE’s FA Score: 1 green, 4 red.
- XXI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BEBE’s TA Score shows that 3 TA indicator(s) are bullish while XXI’s TA Score has 3 bullish TA indicator(s).
- BEBE’s TA Score: 3 bullish, 3 bearish.
- XXI’s TA Score: 3 bullish, 6 bearish.
Price Growth
BEBE (@Financial Conglomerates) experienced а +0.20% price change this week, while XXI (@Other Consumer Specialties) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Financial Conglomerates industry was +0.45%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +2.50%.
The average weekly price growth across all stocks in the @Other Consumer Specialties industry was -9.55%. For the same industry, the average monthly price growth was -19.48%, and the average quarterly price growth was -29.38%.
Reported Earning Dates
BEBE is expected to report earnings on Nov 13, 2026.
XXI is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Financial Conglomerates (+0.45% weekly)Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.
@Other Consumer Specialties (-9.55% weekly)‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.
Advertisement
BEBE and
Correlation & Price change
A.I.dvisor tells us that BEBE and NPAC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEBE and NPAC's prices will move in lockstep.
| Ticker / NAME | Correlation To BEBE | 1D Price Change % | ||
|---|---|---|---|---|
| BEBE | 100% | +0.10% | ||
| NPAC - BEBE | 22% Poorly correlated | -0.19% | ||
| HVMC - BEBE | 21% Poorly correlated | N/A | ||
| XXI - BEBE | 12% Poorly correlated | +2.62% | ||
| CEPF - BEBE | 11% Poorly correlated | +0.10% | ||
| AXP - BEBE | 6% Poorly correlated | -1.22% | ||
More | ||||
XXI and
Correlation & Price change
A.I.dvisor tells us that XXI and GNS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XXI and GNS's prices will move in lockstep.
| Ticker / NAME | Correlation To XXI | 1D Price Change % | ||
|---|---|---|---|---|
| XXI | 100% | +2.62% | ||
| GNS - XXI | 29% Poorly correlated | +0.49% | ||
| LPBBU - XXI | 24% Poorly correlated | N/A | ||
| CHGG - XXI | 24% Poorly correlated | +1.97% | ||
| OACC - XXI | 21% Poorly correlated | N/A | ||
| GOTU - XXI | 20% Poorly correlated | +2.20% | ||
More | ||||